Centre Hospitalier Universitaire Vaudois
Clinical trials sponsored by Centre Hospitalier Universitaire Vaudois, explained in plain language.
-
New hope for recurrent brain cancer: triple drug combo enters human trial
Disease control Recruiting nowThis study tests whether combining an antidepressant (trimipramine) with two cancer drugs (atezolizumab and bevacizumab) can help people whose glioblastoma brain tumor has returned after standard treatment. About 59 participants will receive the drug combination for up to 2 years…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Knee cartilage breakthrough: own cells used to patch defects
Disease control Recruiting nowThis study tests a procedure that uses a patient's own cartilage cells to repair damaged knee cartilage. It involves 218 people aged 15 to 50 with specific knee defects. The goal is to see if this approach is safe and improves knee function and quality of life.
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Your phone could soon check your blood pressure – no cuff needed!
Diagnosis Recruiting nowThis study tests whether a smartphone can reliably screen for high blood pressure by recording video at your fingertip. One hundred adults (some healthy, some with suspected hypertension) will use both a smartphone and a standard blood pressure cuff at home for 7 days. The goal i…
Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Diagnosis
Last updated May 01, 2026 16:01 UTC
-
New ultrasound technique may reduce pain and opioid use in child circumcisions
Symptom relief Recruiting nowThis study tests whether using ultrasound to guide a numbing injection (penile block) before circumcision reduces pain and the need for strong painkillers compared to the standard method. About 216 boys under 18 will be randomly assigned to one of the two techniques. The goal is …
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Symptom relief
Last updated May 01, 2026 16:00 UTC
-
Stroke survivors get intensive tech-powered rehab in swiss study
Symptom relief Recruiting nowThis study tests whether a high-dose, high-intensity neurorehabilitation program is practical and helpful for adults recovering from stroke. Participants will receive about 300 minutes of active, technology-supported training each week, in addition to standard care, across inpati…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Symptom relief
Last updated May 01, 2026 15:56 UTC